Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.
about
Biological Roles of Resolvins and Related Substances in the Resolution of PainObesity and insulin resistance: an abridged molecular correlationResolution phase lipid mediators of inflammation: agonists of resolution.Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and HumansRoles of resolvins in the resolution of acute inflammationLipid mediators in the resolution of inflammationSpecialized pro-resolving mediators: endogenous regulators of infection and inflammationResolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomePro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in InflammationResolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formationProresolving lipid mediators and diabetic wound healingWhat causes the insulin resistance underlying obesity?Metabolic remodeling of white adipose tissue in obesityUnraveling the complex relationship triad between lipids, obesity, and inflammationMacrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls painCommon therapeutic targets in cardiometabolic diseaseAging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicinesMolecular biology for formyl peptide receptors in human diseases.A decade of progress in adipose tissue macrophage biology.Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.Metabolic and immunomodulatory effects of n-3 fatty acids are different in mesenteric and epididymal adipose tissue of diet-induced obese mice.Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetesDocosahexaenoic acid, inflammation, and bacterial dysbiosis in relation to periodontal disease, inflammatory bowel disease, and the metabolic syndrome.Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue.n-3 Fatty acids attenuate the risk of diabetes associated with elevated serum nonesterified fatty acids: the multi-ethnic study of atherosclerosis.Resolvins and protectins in inflammation resolution.Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.Obesity, immunomodulation and chronic kidney disease.Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes.High Amylose White Rice Reduces Post-Prandial Glycemic Response but Not Appetite in Humans.Dual actions of a novel bifunctional compound to lower glucose in mice with diet-induced insulin resistanceResolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.LXA4 actions direct fibroblast function and wound closureLipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney DiseaseIncreased PUFA Content and 5-Lipoxygenase Pathway Expression Are Associated with Subcutaneous Adipose Tissue Inflammation in Obese Women with Type 2 Diabetes.Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fatHigh ω3-polyunsaturated fatty acids in fat-1 mice prevent streptozotocin-induced Purkinje cell degeneration through BDNF-mediated autophagyMolecular targets related to inflammation and insulin resistance and potential interventions
P2860
Q26784433-B51997DF-82C5-4D5E-9310-78223B957464Q26825473-785FB147-48F2-4DD5-9EBB-858155E006C7Q27687489-D79186FA-8E77-4CEB-AB83-66AAEFF230C1Q28075256-CB7CF84F-AACE-43DA-A062-B0936E065D52Q28244502-3A1304F3-FA6B-4D39-AF07-5BBD884B84C9Q28250668-60E60E61-8AE6-477B-8F80-B477E6E414B9Q28271331-A8329022-DA89-443A-B8FF-8414424B5027Q28274076-FD554FEF-65B7-46CC-9CB4-86FB1D65E538Q28387661-C6F825EB-585B-4A4C-B6D2-0B723ACBD873Q28716294-BD2C98C7-EE5F-4F34-9A53-3BB8B97ADC64Q30514238-2D6847EE-F179-4DFF-B8A9-F5CEE028E2E0Q33683848-9D18A9BD-783E-46AD-ABB1-CF438F749D33Q33684984-66613DEC-8866-48B0-9F5B-0C7E6A9466ACQ34001327-94504C91-A874-4120-99D7-D423AAC22C54Q34042152-3919977E-9B7A-414B-BF2C-C5236260DFADQ34130101-FD006F76-B781-4DEA-8857-6A798325BF0EQ34251343-7E034C61-7406-4E0A-B227-588B7FBAB1E3Q34289222-EBE3B1BE-94EE-4B65-A6DA-1F807CF76B96Q34327503-2591103A-4C0F-4821-836F-72968797797FQ34372560-06853C57-AC34-4955-A075-3F4C4DD631F6Q34407602-F1134751-E9F2-4F3E-B102-791F224D477DQ34617826-63BBA8F0-AAE6-4684-BA3E-93B7B3CAF4ADQ34955621-1F526D37-DEDB-4F66-85F7-DDF1746562EFQ34961257-4CDC144B-0144-4B36-95CB-CA9489C0A179Q35114027-D78F7A33-54E4-494A-9D5E-CF87D3419506Q35207918-1EBF136C-94F6-4DF2-9D32-96B74BF3E80BQ35332873-0F26412C-8ECA-4635-A183-241B55DA191AQ35629039-D9A481C8-7F45-477D-8F4C-20D5BE8F57F3Q35640634-E602C9E9-5B12-43AF-9FBB-65BF4A1B6E77Q35674290-08F4DD12-B694-4828-BD22-97664A73583AQ35867508-E3B6A63F-22F1-4A20-985C-819211BC746BQ35894988-B7ED74F9-37B7-4E28-B6FD-23C22F92F819Q35916836-35A8228B-D456-4F2C-B21D-5E5EE0337D76Q35951840-520E97EC-624E-4D9D-B428-737C2A698EF9Q36021645-DDF74507-F164-472D-A99E-A80B3A939B7BQ36095550-65429D96-A60F-4D72-90A8-76DE76A12169Q36102136-0431D14D-EF80-4852-BA86-4D2AF09DBB06Q36179560-05113F55-2C87-49C1-8E66-8594C3267933Q36209582-CDEE0FC9-F78F-4953-8706-9BEF24EA5BA2Q36294297-A5AF393C-7CA9-46A4-8FB2-273B1BCA8DDD
P2860
Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Resolvin D1 decreases adipose ...... tivity in obese-diabetic mice.
@en
type
label
Resolvin D1 decreases adipose ...... tivity in obese-diabetic mice.
@en
prefLabel
Resolvin D1 decreases adipose ...... tivity in obese-diabetic mice.
@en
P2093
P2860
P921
P356
P1433
P1476
Resolvin D1 decreases adipose ...... tivity in obese-diabetic mice.
@en
P2093
Aruni Bhatnagar
Jason Hellmann
Madhavi Kosuri
Matthew Spite
Yunan Tang
P2860
P304
P356
10.1096/FJ.10-178657
P407
P577
2011-04-08T00:00:00Z